本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Biohaven Pharmaceutical Holding Co Ltd.

15.71
+1.4810.40%
成交量:281.48万
成交额:4,343.52万
市值:16.62亿
市盈率:-2.05
高:15.83
开:14.41
低:14.36
收:14.23
52周最高:55.70
52周最低:12.79
股本:1.06亿
流通股本:8,775.36万
量比:1.34
换手率:3.21%
股息:- -
股息率:- -
每股收益(TTM):-7.6523
每股收益(LYR):-9.2774
净资产收益率:-295.94%
总资产收益率:-103.41%
市净率:12.35
市盈率(LYR):-1.69

数据加载中...

2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

重要事件披露

8-K - Current report
2022/09/29

重要事件披露

8-K - Current report
2022/09/27

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/05

重要事件披露

8-K - Current report